Skip to content
10-Q

Quarterly Report

INTERLEUKIN GENETICS INC

0001144204-16-101216

← back to feed
Filed
May 12, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 11, 2016 173.03M sh
Long Term Debt Q1 2016 · Mar 31, 2016 $2.93M
Long Term Debt Q1 2016 · Dec 31, 2015 $3.47M
Short Term Debt Q1 2016 · Mar 31, 2016 $1.83M
Short Term Debt Q1 2016 · Dec 31, 2015 $1.33M
Stockholders Equity Q1 2016 · Mar 31, 2016 −$3.76M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$2.46M
Current Liabilities Q1 2016 · Mar 31, 2016 $5.44M
Current Liabilities Q1 2016 · Dec 31, 2015 $5.48M
Total Liabilities Q1 2016 · Mar 31, 2016 $8.37M
Total Liabilities Q1 2016 · Dec 31, 2015 $8.95M
Current Assets Q1 2016 · Mar 31, 2016 $3.94M
Current Assets Q1 2016 · Dec 31, 2015 $5.7M
Total Assets Q1 2016 · Mar 31, 2016 $4.62M
Total Assets Q1 2016 · Dec 31, 2015 $6.49M
Capex Q1 2016 · Mar 31, 2015 $16.93K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $9.64M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $11.47M
Sga Expense Q1 2016 · Mar 31, 2015 $1.56M
Rd Expense Q1 2016 · Mar 31, 2015 $182.53K
Net Income Q1 2016 · Mar 31, 2015 −$1.84M
Net Income Q1 2016 · Dec 31, 2014 $6.3M
Operating Income Q1 2016 · Mar 31, 2015 −$1.69M
Gross Profit Q1 2016 · Mar 31, 2015 $72.17K
Cost Of Revenue Q1 2016 · Mar 31, 2015 $331.04K
Revenue Q1 2016 · Mar 31, 2015 $403.21K